Metraipolis › archive › dc_9816978ee65d
Efficacy and safety of dinutuximab beta combined with GM-CSF and isotretinoin ± chemotherapy as first-line maintenance treatment for pediatric high-risk… — Europe PMC PMID:41737488
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41737488
- DOI
- 10.3389/fonc.2026.1765578
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T00:43:26.518Z
- SHA-256 of the archived text
af0fda05023044b7372bc26641190bc9486ec68da6efdd33526449e05028174b- Stable URL of this page
https://metraipolis.com/documento/dc_9816978ee65d
How to cite
Efficacy and safety of dinutuximab beta combined with GM-CSF and isotretinoin ± chemotherapy as first-line maintenance treatment for pediatric high-risk… — Europe PMC PMID:41737488 — Europe PMC (en), https://europepmc.org/article/MED/41737488 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9816978ee65d (Metraipolis archive dc_9816978ee65d, sha256 af0fda05023044b7372bc26641190bc9486ec68da6efdd33526449e05028174b)
BibTeX
@misc{dc9816978ee65d,
title = {Efficacy and safety of dinutuximab beta combined with GM-CSF and isotretinoin ± chemotherapy as first-line maintenance treatment for pediatric high-risk… — Europe PMC PMID:41737488},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41737488},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9816978ee65d; sha256 af0fda05023044b7372bc26641190bc9486ec68da6efdd33526449e05028174b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41737488. Agents can read the archived copy with the MCP tool read_document.